Albert JS and Rippe JM: Manual of Cardiovascular Diagnosis and Therapy. Boston , Little, Brown and Company, 1980 , pp. 30-36.
2.
Zipes DP and Troup PJ: The New Antiarrhythmic Agents: Amiodarone, Aprindine, Disopyramide, Ethmozin, Mexilitene, Tocainide, Verapamil. Am J Cardiol41:1005, 1978.
3.
Electrophysiologic and AntiarrhythmicEffects of Antiarrhythmic Drugs. In: Heart Disease—A Textbook of Cardiovascular Medicine, ed. by Braunwald E, Phila., W.B. Saunders Co. , 1980, pp. 693-706.
4.
Annsdorf MF: Electrophysiologic Properties of Antiarrhythmic Drugs as a Rational Basis for Therapy. Med Clin No Amer60:213-232, 1975.
5.
Quinidine.In: Heart Disease—A Textbook of Cardiovascular Medicine, ed. by Braunwald E, Phila.,W.B. Saunders Co., 1980, pp. 706-710.
6.
Denes P., Gabster A., Huang SK: Clinical, Electrocardiographic, and Follow-Up Observations in Patients Having Ventricular Fibrillation During Holter Monitoring. Role of Quinidine Therapy . Am J Cardiol48:9-16, 1981.
7.
Koster R., Wellens Hjj: Quinidine Induced Ventricular Flutter and Fibrillation Without Digitalis Therapy . Am J Cardiol38:519, 1976.
8.
Leahy EF, Reiffel JA, Giardina EV, Bigger JT, Jr: The Effect of Quinidine and Other Oral Antiarrhythmic Drugs on Serum Digoxin . Annals Int Med92:605-608, 1980.
9.
Procainamide.In: Heart Disease—A Textbook of Cardiovascular Medicine, ed. by Braunwald E.Phila, W.B. Saunders Co., 1980, pp. 710-713.
Winkle RA, Glant SA, Harrison DC: Pharmacologic Therapy of Ventricular Arrhythmias. Am J Cardiol36:629-650, 1975.
12.
Giardina EV , Tenster PE, Bigger JT, Jr, et al: Efficacy, Plasma Concentrates and Adverse Effects of a New Sustained Release Procainamide Preparation. Am J Cardiol46:855-862, Nov., 1980.
13.
Stec GP, Lertora Jjl, Atkinson AJ, et al: Remission of Procainamide—Induced Lupus Erythematosis with NAPA Therapy—Brief Report. Annals Int Med90:799-800, 1979.
14.
Alper JS and Franus GS: Manual of Coronary Care, 2nd Ed., Boston, Little, Brown and Co., 1980 , pp. 59-63.
15.
Myerburg RJ , Conde C., Sheps DS, et al: Antiarrhythmic Drug Therapy in Survivors of Prehospital Cardiac Arrest. Circulation59:855-863, 1979.
16.
Lown B., Graboys TB: Management of Patients with Malignant Ventricular Arrhythmias. Am J Cardiol39:910, 1977.
17.
Winkle RA, Gradman AH, Fitzgerald JW, Bell PH: Antiarrhythmic Drug Effect Assessed from Ventricular Arrhythmia Reduction in the Ambulatory ECG and Treadmill Test—Comparison of Propranolol, Procainamide, and Quinidine. Am J Cardiol42:473-480, Sept. 1978.
18.
Warnowicz MA , Denes P.: Chronic Ventricular Arrhythmias: Comparative Drug Effectiveness and Toxicity. Prog Cardiovasc Dis23:225-236, 1980.
19.
Horowitz LN , Josephson ME, Kastor JA: Intracardiac Electrophysiologic Studies as a Method for the Optimization of Drug Therapy in Chronic Ventricular Arrhythmia . Prog Cardiovasc Dis23:81-98, 1980.